YC S24
Biocartesian
Converting biology into digital molecular maps
About
Finding new cures requires seeing what and where the abnormal molecules are in a diseased tissue, but current tools see less than 1% of those molecules. Biocartesian combines microscopy and new chemistries to see 50X more, offering unprecedented insights into disease biology and new therapies.
Founders
- Ian Dardani
- Jess Li
Family Office Investors
Altss tracks family office allocations to YC-backed companies. Request access to see which family offices have invested in Biocartesian.
See family office activityIndustry & Focus
HealthcareDrug Discovery and DeliveryHard TechB2BBiotechDiagnosticsDrug discovery